Alzheimer's Disease Clinical Trials in Chicago, Illinois

5 studies are recruiting for alzheimer's disease in Chicago, Illinois right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

    The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease

    Stage
    Phase 3
    Ages
    60 to 85
    Site
    Great Lakes Clinical Trials - Andersonville, Chicago, Illinois
    Locations
    127 in total
    Run by
    Bristol-Myers Squibb
  2. A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

    The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease

    Stage
    Phase 3
    Ages
    60 to 85
    Site
    Re:Cognition Health - Chicago, Chicago, Illinois
    Locations
    119 in total
    Run by
    Bristol-Myers Squibb
  3. Central Auditory Processing Modulation Underlying Anxiety Reduction Using Clinically Designed Improvisatory Music

    This study examines whether Clinically Designed Improvisatory Music (CDIM) can reduce anxiety in people living with Alzheimer's disease and anxiety (AD-A), and whether it can also lessen caregiver burden. CDIM is a live, receptive music-based intervention that uses slow tempi, simple diatonic melod…

    Stage
    Not phased
    Ages
    55 and older
    Site
    Northwestern University Feinberg School of Medicine, Chicago, Illinois
    Run by
    Northwestern University
  4. Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device

    This study compares p-tau217 concentrations in blood collected via the Tasso device versus standard venipuncture in subjects with and without Alzheimer's disease, including a subset with confirmed amyloid pathology.

    Stage
    Not phased
    Ages
    40 to 90
    Site
    Insigth Hospital and Medical Center Chicago, Chicago, Illinois
    Locations
    5 in total
    Run by
    Neurogen Biomarking LLC
  5. Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

    Bio-Hermes-002 is a 120-day cross-sectional study that will result in a blood, CSF, retinal, digital, MRI, and PET brain imaging biomarker database that can be used to determine the primary objective. Digital biomarkers and blood-based biomarkers will be tested to determine whether a meaningful rel…

    Stage
    Not phased
    Ages
    60 to 90
    Site
    Flourish Research - Chicago, Chicago, Illinois
    Locations
    26 in total
    Run by
    GAP Innovations, PBC

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.